scispace - formally typeset
Open AccessJournal Article

K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease

Shaul G. Massry, +80 more
- 01 Oct 2003 - 
- Vol. 42
Reads0
Chats0
About
This article is published in American Journal of Kidney Diseases.The article was published on 2003-10-01 and is currently open access. It has received 2609 citations till now. The article focuses on the topics: Chronic kidney disease-mineral and bone disorder & Kidney disease.

read more

Citations
More filters
Journal ArticleDOI

25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients

TL;DR: It is suggested that lower levels of [25(OH)D3] are a cardiovascular risk marker in HD patients, since they are strongly associated with higher BNP levels, increased PP and with the presence of vascular calcifications.
Journal ArticleDOI

High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.

TL;DR: In this paper, a prospective study was conducted to evaluate dosing, safety and tolerability of cholecalciferol supplementation in haemodialysis patients, where patients were randomized to a treated group and an untreated group.
Journal ArticleDOI

Influence of Industry on Renal Guideline Development

TL;DR: The recent KDOQI anemia guidelines increased the target hemoglobin range from 11 to 12 to 11 to 13 g/dl for all patients with chronic kidney disease (CKD) as discussed by the authors.
Journal ArticleDOI

Mineral Metabolites and CKD Progression in African Americans

TL;DR: In conclusion, abnormalities of mineral metabolism worsen with progressive CKD and associate with higher risk for ESRD among African Americans with hypertensive nephrosclerosis.
References
Related Papers (5)